Capricor Therapeutics Inc (CAPR)

REAL ESTATE: REAL ESTATE MANAGEMENT & DEVELOPMENT
SIC: PHARMACEUTICAL PREPARATIONS

8840 WILSHIRE BLVD BEVERLY HILLS, CA 90211

Capricor Therapeutics, Inc., is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and the cytokine storm associated with COVID-19. Capricor is also investigating the field of extracellular vesicles and exploring the potential of exosome-based candidates to treat or prevent a variety of disorders. We are now developing two potential vaccines for COVID-19 as part of our exosome platform.

Data as of 2021-07-25 16:34:17 -0400
Market Cap111.187 Million Shares Outstanding22.878 Million Avg 30-day Volume222.537 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.79 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.11396 52-week High/Low12.32 / 3.13 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -22.7115
Data provided by IEX Cloud
View SEC Filings from CAPR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 30 25 20.0% 8 (0.47%) 6 (0.35%) 33.33%
13F shares: 4.352 Million 1.491 Million 191.93% 2.567 Million 358.904 Thousand 615.13%
% Ownership 19.0878 7.29 161.84% 11.2582 1.7552 541.42%
New Positions: 9 5 80.0% 2 2 0.0%
Increased Positions 6 10 -40.0% 2 4 -50.0%
Closed Positions 4 5 -20.0%
Reduced Positions 8 5 60.0% 4
Total Calls 204.605 Thousand 209.135 Thousand -2.17% 76.2 Thousand 36.71 Thousand 107.57%
Total Puts 304.188 Thousand 261.739 Thousand 16.22% 49.4 Thousand 64.8 Thousand -23.77%
PUT/CALL Ratio 1.49 1.25 19.2% 0.65 1.77 -63.28%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CAPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAPR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SABAR KARIMAH ES

  • Director
115,000 2021-07-23 2

LITVACK FRANK

  • Director
0 2021-01-04 1

COLLIER EARL M JR

  • Director
0 2021-01-04 1

MUSKET DAVID B

  • Director
0 2021-01-04 1

MARBAN LINDA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-04 1

MANZO LOUIS

  • Director
0 2021-01-04 2

KRASNEY KAREN EVP, GENERAL COUNSEL

  • Officer
0 2021-01-04 1

BERGMANN ANTHONY CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-04 1

DUNBAR GEORGE W JR

  • Director
0 2021-01-04 1

ASCHEIM DEBORAH CHIEF MEDICAL OFFICER

  • Officer
0 2018-07-24 0

KAZAM JOSHUA A

  • Director
0 2018-01-02 0

SMITH RACHEL VICE PRESIDENT OF R&D

  • Officer
0 2018-01-02 0

CEDARS SINAI MEDICAL CENTER

  • 10% Owner
4,049,959 2017-05-09 0

MARBAN EDUARDO

  • 10% Owner
3,307,863 2016-12-31 0

GRASMICK LOUIS J

  • Director
1,136,755 2016-03-16 0

ST. JOHN EDWARD A.

EDWARD ST. JOHN, LLC

  • 10% Owner
5,175,958 2016-03-16 0

GERSHELL LELAND CHIEF FINANCIAL OFFICER

  • Officer
2,100 2016-03-16 0

HAMER ANDREW WARWICK VP OF MEDICAL AFFAIRS

  • Officer
0 2015-03-03 0

SCHAFER GREGORY W

  • Director
0 2015-03-03 0

DAVIES ANTHONY CHIEF TECHNOLOGY OFFICER

  • Officer
0 2013-11-20 0

ST. JOHN EDWARD A.

MD BTI, LLC

EDWARD ST. JOHN, LLC

  • 10% Owner
5,047,221 2013-11-20 0

HORTON DARLENE P PRESIDENT & CEO

  • Officer
  • Director
0 2012-08-06 0

BREWER RICHARD B EXECUTIVE CHAIRMAN

  • Officer
  • Director
125,000 2012-03-30 0

LIEU HSIAO EXECUTIVE VP, CLINICAL DEV.

  • Officer
12,600 2012-03-30 0

EVANS DARON CHIEF FINANCIAL OFFICER

  • Officer
36,252 2012-03-30 0

KASH PETER M

  • Director
2,258,327 2011-07-18 0

MIEYAL PAUL A

  • Director
0 2011-05-10 0

GRANADILLO PEDRO P

  • Director
27,588 2011-05-10 0

BELLDEGRUN ARIE

  • Director
711,420 2011-05-10 0

TANEN DAVID M

  • Director
No longer subject to file 2009-12-31 0

STRUMPH PETER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2009-01-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SABAR KARIMAH ES - Director

2021-07-27 18:31:54 -0400 2021-07-23 A 115,000 a 115,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 18:15:03 UTC -11.074 11.134 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 17:45:03 UTC -11.074 11.134 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 17:15:03 UTC -11.074 11.134 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 16:45:03 UTC -11.0332 11.1132 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 16:15:03 UTC -11.0332 11.1132 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 15:45:03 UTC -11.0332 11.1132 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 15:15:03 UTC -11.0332 11.1132 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 14:45:03 UTC -10.5024 10.5824 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 14:15:03 UTC -10.5024 10.5824 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 13:45:03 UTC -10.5024 10.5824 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 13:15:04 UTC -10.5024 10.5824 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-08-02 12:45:03 UTC -10.5024 10.5824 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 22:15:02 UTC -10.5024 10.5824 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 21:45:03 UTC -10.4707 10.5507 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 21:15:03 UTC -10.4707 10.5507 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 20:45:02 UTC -10.4823 10.5623 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 20:15:02 UTC -10.4823 10.5623 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 19:45:03 UTC -10.4823 10.5623 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 19:15:02 UTC -10.4823 10.5623 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-07-30 18:45:03 UTC -10.4922 10.5722 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments